Analyses de cycle de vie des médicaments à l’hôpital : faisabilité et perspectives d’intégration, application à l’adalimumab
- DOI
- 10.1016/j.pharma.2026.03.002
- Published
- 2026-03
- Container
- Annales Pharmaceutiques Françaises
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.pharma.2026.03.002,
title = {Analyses de cycle de vie des médicaments à l’hôpital : faisabilité et perspectives d’intégration, application à l’adalimumab},
author = {Virginie Siorat and Marion Tano and Olivier Parent de Curzon and Pascal Paubel and Albane Degrassat-Théas},
year = {2026},
journal = {Annales Pharmaceutiques Françaises},
doi = {10.1016/j.pharma.2026.03.002},
url = {https://doi.org/10.1016/j.pharma.2026.03.002}
}RIS
TY - JOUR TI - Analyses de cycle de vie des médicaments à l’hôpital : faisabilité et perspectives d’intégration, application à l’adalimumab AU - Virginie Siorat AU - Marion Tano AU - Olivier Parent de Curzon AU - Pascal Paubel AU - Albane Degrassat-Théas PY - 2026 JO - Annales Pharmaceutiques Françaises DO - 10.1016/j.pharma.2026.03.002 UR - https://doi.org/10.1016/j.pharma.2026.03.002 ER -
APA
Siorat, V., Tano, M., Curzon, O. P. D., Paubel, P., & Degrassat-Théas, A. (2026). Analyses de cycle de vie des médicaments à l’hôpital : faisabilité et perspectives d’intégration, application à l’adalimumab. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.03.002
Source records
- crossref · retrieved 2026-09-25T20:41:15.606Z